Ratiometric Activatable Cell-Penetrating Peptides Label Pancreatic Cancer, Enabling Fluorescence-Guided Surgery, Which Reduces Metastases and Recurrence in Orthotopic Mouse Models

被引:38
作者
Metildi, Cristina A. [1 ]
Felsen, Csilla N. [2 ]
Savariar, Elamprakash N. [2 ]
Nguyen, Quyen T. [1 ,3 ]
Kaushal, Sharmeela [3 ]
Hoffman, Robert M. [1 ,3 ,4 ]
Tsien, Roger Y. [2 ,3 ,5 ]
Bouvet, Michael [1 ,3 ]
机构
[1] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA
[2] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA
[3] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA
[4] AntiCancer Inc, San Diego, CA USA
[5] Univ Calif San Diego, Howard Hughes Med Inst, San Diego, CA 92103 USA
基金
英国惠康基金;
关键词
ANTI-CEA ANTIBODY; HUMAN COLON-CANCER; MATRIX METALLOPROTEINASES; TUMOR; RESECTION; PROTEIN; GFP;
D O I
10.1245/s10434-014-4144-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to evaluate the efficacy of using matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9)-cleavable ratiometric activatable cell-penetrating peptides (RACPPs) conjugated to Cy5 and Cy7 fluorophores to accurately label pancreatic cancer for fluorescence-guided surgery (FGS) in an orthotopic mouse model. Orthotopic mouse models were established using MiaPaCa-2-GFP human pancreatic cancer cells. Two weeks after implantation, tumor-bearing mice were randomized to conventional white light reflectance (WLR) surgery or FGS. FGS was performed at far-red and infrared wavelengths with a customized fluorescence-dissecting microscope 2 h after injection of MMP-2 and MMP-9-cleavable RACPPs. Green fluorescence imaging of the GFP-labeled cancer cells was used to assess the effectiveness of surgical resection and monitor recurrence. At 8 weeks, mice were sacrificed to evaluate tumor burden and metastases. Mice in the WLR group had larger primary tumors than mice in the FGS group at termination [1.72 g +/- A standard error (SE) 0.58 vs. 0.25 g +/- A SE 0.14; respectively, p = 0.026). Mean disease-free survival was significantly lengthened from 5.33 weeks in the WLR group to 7.38 weeks in the FGS group (p = 0.02). Recurrence rates were lower in the FGS group than in the WLR group (38 vs. 73 %; p = 0.049). This translated into lower local and distant recurrence rates for FGS compared to WLR (31 vs. 67 for local recurrence, respectively, and 25 vs. 60 % for distant recurrence, respectively). Metastatic tumor burden was significantly greater in the WLR group than in the FGS group (96.92 mm(2) +/- A SE 52.03 vs. 2.20 mm(2) +/- A SE 1.43; respectively, chi (2) = 5.455; p = 0.02). RACPPs can accurately and effectively label pancreatic cancer for effective FGS, resulting in better postresection outcomes than for WLR surgery.
引用
收藏
页码:2082 / 2087
页数:6
相关论文
共 29 条
[21]   An LED Light Source and Novel Fluorophore Combinations Improve Fluorescence Laparoscopic Detection of Metastatic Pancreatic Cancer in Orthotopic Mouse Models [J].
Metildi, Cristina A. ;
Kaushal, Sharmeela ;
Lee, Claudia ;
Hardamon, Chanae R. ;
Snyder, Cynthia S. ;
Luiken, George A. ;
Talamini, Mark A. ;
Hoffman, Robert M. ;
Bouvet, Michael .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2012, 214 (06) :997-U193
[22]   Fluorescence-guided surgery with live molecular navigation - a new cutting edge [J].
Nguyen, Quyen T. ;
Tsien, Roger Y. .
NATURE REVIEWS CANCER, 2013, 13 (09) :653-662
[23]   Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival [J].
Nguyen, Quyen T. ;
Olson, Emilia S. ;
Aguilera, Todd A. ;
Jiang, Tao ;
Scadeng, Miriam ;
Ellies, Lesley G. ;
Tsien, Roger Y. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (09) :4317-4322
[24]   In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer [J].
Olson, Emilia S. ;
Aguilera, Todd A. ;
Jiang, Tao ;
Ellies, Lesley G. ;
Nguyen, Quyen T. ;
Wong, Edmund H. ;
Gross, Larry A. ;
Tsien, Roger Y. .
INTEGRATIVE BIOLOGY, 2009, 1 (5-6) :382-393
[25]   Real-time In Vivo Molecular Detection of Primary Tumors and Metastases with Ratiometric Activatable Cell-Penetrating Peptides [J].
Savariar, Elamprakash N. ;
Felsen, Csilla N. ;
Nashi, Nadia ;
Jiang, Tao ;
Ellies, Lesley G. ;
Steinbach, Paul ;
Tsien, Roger Y. ;
Nguyen, Quyen T. .
CANCER RESEARCH, 2013, 73 (02) :855-864
[26]   The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer [J].
Stiles, BM ;
Bhargava, A ;
Adusumilli, PS ;
Stanziale, SF ;
Kim, TH ;
Rusch, VW ;
Fong, YM .
SURGERY, 2003, 134 (02) :357-364
[27]   Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial [J].
Stummer, W ;
Pichlmeier, U ;
Meinel, T ;
Wiestler, OD ;
Zanella, F ;
Hans-Jurgen, R .
LANCET ONCOLOGY, 2006, 7 (05) :392-401
[28]   The FLARE™ Intraoperative Near-Infrared Fluorescence Imaging System: A First-in-Human Clinical Trial in Breast Cancer Sentinel Lymph Node Mapping [J].
Troyan, Susan L. ;
Kianzad, Vida ;
Gibbs-Strauss, Summer L. ;
Gioux, Sylvain ;
Matsui, Aya ;
Oketokoun, Rafiou ;
Ngo, Long ;
Khamene, Ali ;
Azar, Fred ;
Frangioni, John V. .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (10) :2943-2952
[29]   Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results [J].
van Dam, Gooitzen M. ;
Themelis, George ;
Crane, Lucia M. A. ;
Harlaar, Niels J. ;
Pleijhuis, Rick G. ;
Kelder, Wendy ;
Sarantopoulos, Athanasios ;
de Jong, Johannes S. ;
Arts, Henriette J. G. ;
van der Zee, Ate G. J. ;
Bart, Joost ;
Low, Philip S. ;
Ntziachristos, Vasilis .
NATURE MEDICINE, 2011, 17 (10) :1315-U202